NCT06084416
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06084416
Title A Study of Sovilnesib in Subjects With Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase I
Variant Requirements Yes
Sponsors Volastra Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
The University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 United States Details
UCLA Los Angeles California 90095 United States Details
Hoag Memorial Hospital Newport Beach California 92663 United States Details
Georgia Cancer Center Augusta University Atlanta Georgia 30912 United States Details
Johns Hopkins Hospital Baltimore Maryland 21287 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Corewell Health Grand Rapids Michigan 49503 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10128 United States Details
OU Health Stephenson Cancer Center Oklahoma City Oklahoma 73117 United States Details
MUSC Hollings Cancer Center Charleston South Carolina 29020 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field